Adimmune Corporation (TPE:4142)

Taiwan · Delayed Price · Currency is TWD

17.40

-0.40 (-2.25%)

Mar 4, 2026, 1:15 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Revenue from Internal Divisions	-21.16M	-27.03M	-119.03M	-22.00M	-
Antero Biotechnology	39.92M	43.49M	188.42M	109.82M	-
Antero Biotechnology Growth	-8.23%	-76.92%	71.56%	-	-
Guoguang Biotechnology	1.54B	1.77B	2.18B	1.71B	-
Guoguang Biotechnology Growth	-13.03%	-18.95%	27.92%	-	-
Pharmaceuticals	-	-	-	-	1.87B
Pharmaceuticals Growth	-	-	-	-	43.81%
Total	1.56B	1.79B	2.25B	1.79B	1.87B
Total Growth	-12.78%	-20.72%	25.52%	-4.03%	43.81%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Taiwan	760.25M	842.44M	959.02M	961.50M	1.29B
Taiwan Growth	-9.76%	-12.16%	-0.26%	-25.58%	89.57%
USA	376.93M	326.82M	345.66M	456.18M	496.21M
USA Growth	15.33%	-5.45%	-24.23%	-8.07%	-
China	349.03M	477.56M	632.10M	183.88M	31.53M
China Growth	-26.91%	-24.45%	243.76%	483.13%	-
Other	70.78M	138.28M	314.84M	192.21M	49.35M
Other Growth	-48.82%	-56.08%	63.80%	289.45%	-92.02%
Total	1.56B	1.79B	2.25B	1.79B	1.87B
Total Growth	-12.78%	-20.72%	25.52%	-4.03%	43.81%

Source: S&P Global Market Intelligence.